Indication
optic neuritis
4 clinical trials
4 products
1 drug
Product
OCS-05Clinical trial
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of OCS-05 in Patients With Acute Optic NeuritisStatus: Recruiting, Estimated PCD: 2023-10-30
Clinical trial
Edaravone in the Treatment of Aquaporin-4 Antibody-positive Optic NeuritisStatus: Recruiting, Estimated PCD: 2024-12-31
Product
EdaravoneClinical trial
A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Clemastine Fumarate as a Remyelinating Agent in Acute Optic NeuritisStatus: Recruiting, Estimated PCD: 2024-08-01
Product
ClemastineDrug
VarlilumabClinical trial
A Pilot Randomized Trial of Efgartigimod Alfa for the Treatment of Incident Moderate to Severe Acute Optic NeuritisStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Product
Efgartigimod